Concepedia

Publication | Closed Access

Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen

DOI

56

Citations

41

References

2013

Year

Diana Ramirez-Ardila, Jean Helmijr, Maxime P. Look, Irene Lurkin, Kirsten Ruigrok-Ritstier, Steven Van Laere, Luc Dirix, Fred C.G.J. Sweep, Paul N. Span, Sabine C. Linn,
Breast Cancer Research and Treatment

References

YearCitations

Page 1